E-LIB Suche - Ergebnisse für: Ray Coquard, I.L.

1

19P Long term sexual disorders among rare ovarian cancer su..:

Dubot, C. ; Joly Lobbedez, F. ; Ray Coquard, I.L....
ESMO Open. 8 (2023) 1 - p. 101040 , 2023

Link: https://doi.org/10.1016/..

2

Economic Impact of Centralized Histological Reviews in Pati..:

Perrier, L. ; Kembou, Nzale S. ; Rascle, P....
Value in Health. 17 (2014) 7 - p. A624 , 2014

Link: https://doi.org/10.1016/..

3

CA1 Discordant Diagnoses in Sarcoma, GIST and Desmoide Tumo..:

Perrier, L. ; Ranchr̀e Vince, D. ; Terrier, P....
Value in Health. 15 (2012) 7 - p. A285 , 2012

Link: https://doi.org/10.1016/..

4

PRM143 Cluster Analysis and Principal Component Analysis to..:

Perrier, L. ; Buja, A. ; Mastrangelo, G....
Value in Health. 15 (2012) 7 - p. A486 , 2012

Link: https://doi.org/10.1016/..

5

8003 ORAL Experience With Bevacizumab in the Management of ..:

Dubot, C. ; Emile, G.A. ; Lhomme, C....
European Journal of Cancer. 47 (2011) - p. S528 , 2011

Link: https://doi.org/10.1016/..

6

19P Long-term fatigue after treatments for non-epithelial o..:

Dubot, C. ; Ray-Coquard, I.L. ; Pautier, P....
ESMO Open. 9 (2024) - p. 102558 , 2024

Link: https://doi.org/10.1016/..

7

55O IMADGIST: A randomized study of 6 vs 3 years of adjuvan..:

Le Cesne, A. ; Chabaud, S. ; Bouche, O....
ESMO Open. 9 (2024) - p. 102445 , 2024

Link: https://doi.org/10.1016/..

8

59P Real-world effectiveness of niraparib in recurrent ovar..:

Hanvic, B. ; Macouillard, P. ; Gladieff, L....
ESMO Open. 9 (2024) - p. 103566 , 2024

Link: https://doi.org/10.1016/..

9

59MO COTESARC – A multicentre, phase I-II clinical trial ev..:

Dufresne, A. ; Brahmi, M. ; Cropet, C....
ESMO Open. 9 (2024) - p. 102449 , 2024

Link: https://doi.org/10.1016/..

10

34O ROCSAN: A multicentric randomized phase II/III evaluati..:

Ray-Coquard, I.L. ; Bellesoeur, A. ; Fabbro, M....
ESMO Open. 9 (2024) - p. 103534 , 2024

Link: https://doi.org/10.1016/..

11

VP3-2024: A randomized study of 6 vs 3 years of adjuvant im..:

Le Cesne, A. ; Schiffler, C. ; Bouche, O....
Annals of Oncology. 35 (2024) 6 - p. 576-577 , 2024

Link: https://doi.org/10.1016/..

12

52O Resistance to imatinib induced by treatment interruptio..:

Blay, J-Y. ; Devin, Q. ; Duffaud, F....
ESMO Open. 9 (2024) - p. 102442 , 2024

Link: https://doi.org/10.1016/..

13

46MO What are the predictors of the success of interval deb..:

Marchetti, C. ; Colomban, O. ; Fagotti, A....
ESMO Open. 9 (2024) - p. 103553 , 2024

Link: https://doi.org/10.1016/..

14

Should all advanced BRCA-mutated patients in response to fi..:

Turinetto, M. ; Ray-Coquard, I. ; Gourley, C.
ESMO Open. 9 (2024) 5 - p. 102983 , 2024

Link: https://doi.org/10.1016/..

15

Improved nationwide survival of sarcoma patients with a net..:

Blay, J.Y. ; Penel, N. ; Valentin, T....
Annals of Oncology. 35 (2024) 4 - p. 351-363 , 2024

Link: https://doi.org/10.1016/..